China Tian Yuan Healthcare Group

Name

China Tian Yuan Healthcare Group

Legal name

China Tian Yuan Healthcare Group Limited

Website

http://www.tianyuanhealthcare.com/

Company type

Public

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Wan Chai

HQ country

Hong Kong SAR China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Healthcare Services Operations: Operating plastic surgery hospitals and IVF services hospitals in China and Asia markets through acquisitions and organic development
2. Investment Holdings: Investment holding company generating returns through equity investments in healthcare businesses

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

China Tian Yuan Healthcare Group operates healthcare services through acquired hospitals and brand partnerships, focusing on two core segments: (1) Plastic surgery services, including a wholly-owned Shanghai hospital with four-grade plastic surgery qualifications and the acquired trademark of South Korea's leading plastic surgery brand, and (2) IVF / assisted reproductive services through hospitals in China and other Asia markets. The company is an investment holding company that pivoted from hospitality to deliver high-end, personalized medical services targeting female customers.

Product overview

China Tian Yuan Healthcare Group Limited (TYHC) is an investment holding company that has transitioned from the hospitality industry to healthcare services. The company operates two primary business segments: Plastic Surgery Services (acquired hospital with four-grade qualifications in Shanghai, trademark rights to South Korea's leading plastic surgery brand) and IVF/Assisted Reproductive Services (hospitals in China and Asia markets). The company aims to become a leading healthcare management organization dedicated to providing high-end and personalized medical services to female customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Plastic Surgery Services Plastic and cosmetic surgery medical services delivered through an acquired Shanghai hospital with four-grade plastic surgery qualifications spanning over 5,000 square meters, together with acquired trademark rights to South Korea's leading plastic surgery brand used to explore the China and South Korea markets and build domestic private hospitals. Targeted at female customers seeking high-end, personalized plastic surgery.
• IVF (Assisted Reproductive Services) Assisted reproductive IVF services hospitals operating in China and other Asia markets, representing the Group's core expansion business in reproductive healthcare, targeted at female customers seeking high-quality fertility treatment.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• South Korean Plastic Surgery BrandcoreOEM/ Whitelabel/ Licensing PartnerTYHC completed acquisition of trademark for South Korea's leading plastic surgery brand to explore China and South Korea market, including building domestic and private hospitals.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Jinxin Fertility Group: Hong Kong-listed (HKEX) IVF and assisted reproductive services operator in China, the largest domestic IVF chain. Directly comparable to TYHC's IVF segment as a public peer competing for the same patient base and physician talent.
• ID Hospital Korea: Leading South Korean plastic surgery hospital chain serving both domestic and international (including Chinese medical tourist) patients. Closely comparable to TYHC's plastic surgery strategy of leveraging Korean brand expertise for the Chinese market.
• BK Plastic Surgery Hospital: Major Korean plastic surgery brand with established China-facing medical tourism flow. Comparable to TYHC's strategy of acquiring a "leading Korean plastic surgery trademark" to serve Chinese premium cosmetic demand.
• Wonjin Plastic Surgery: Large Korean cosmetic surgery group with significant Chinese clientele. Comparable to TYHC in the cross-border Korean cosmetic surgery space and brand-driven positioning.
• Grand Plastic Surgery Korea: Prominent Korean plastic surgery brand with established presence in medical tourism. Relevant peer for TYHC's Korean trademark acquisition strategy and premium positioning.

Broad incumbents

• Phoenix Healthcare Group: Hong Kong-listed (HKEX) private hospital operator in China. Comparable as a HK-listed private healthcare platform, though diversified across general hospital services rather than focused on cosmetics/IVF.
• China Medical and HealthCare Group: Hong Kong-listed healthcare group operating hospitals and clinics in China. Comparable as a HK-listed private healthcare operator, with broader portfolio rather than TYHC's narrow female-premium focus.

Regional players

• Modern Dental Group: Hong Kong-listed specialty healthcare services group. Comparable as a HK-listed specialty healthcare distribution/services operator, though in dental rather than cosmetic/IVF.
• Meiwei Medical (美维口腔): Chinese private specialty healthcare chain operator (dental focus). Comparable as a domestically-built specialty healthcare chain in China pursuing premium positioning and M&A roll-up.

Emerging players

• RAKB Hospital / Aster DM Healthcare: Cross-border (Asia/Middle East) hospital operator with a focus on premium patient services and medical tourism. Comparable to TYHC's cross-border premium positioning strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Customer concentration

• LinkedInlinkedin.com/company/china-tian-yuan-healthcare-group-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about China Tian Yuan Healthcare Group